Compare Corning Incorporated (GLW) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Corning Incorporated vs Hinge Health Inc. Class A Common Stock — how do they compare? Corning Incorporated trades at $136.36 (market cap $127.95B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Corning Incorporated is far larger — about 15.1× Hinge Health Inc. Class A Common Stock's market cap, and Corning Incorporated pays a 0.75% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corning Incorporated for 36 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| GLW | HNGE | |
|---|---|---|
Market Cap | $127.95B | $8.48B |
Volume | 7,325,250 | 879,799 |
Sector | Technology | Health |
52-Week High | $255.79 | $105.14 |
52-Week Low | $78.03 | $31.17 |
Typical Hold Time | 36 Days | 0 Days |
Enterprise Value | $134.83B | $8.10B |
Dividend Yield | 0.75% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Corning (GLW) trades at $140.91, down 4.31% today, amid a bearish technical outlook despite strong fundamentals. The stock shows robust earnings beats in recent quarters and recently secured a significant $3 billion fiber supply agreement with AT&T, positioning it well for AI-driven infrastructure demand. Analyst consensus remains bullish with a $171.25 price target, though technical indicators signal near-term weakness with support at $134.
GLW presents a compelling long-term investment opportunity driven by its leadership in optical communications and materials science, supported by strong revenue growth and improving profit margins. Key risks include ongoing patent litigation and market volatility, but institutional confidence remains high with 57% buy ratings and projected 2026 revenue growth to $17 billion.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Corning Incorporated
Corning Inc is a leader in materials science, specializing in the production of glass, ceramics and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.
Read more on GLW →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
